Loading...

InterCure Ltd.

INCR•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.54
$0.00(0.00%)

InterCure Ltd. (INCR) Company Profile & Overview

Explore InterCure Ltd.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

InterCure Ltd. (INCR) Company Profile & Overview

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOAlexander Rabinovich

Contact Information

https://www.intercure.co
972 7 7460 5012
85 Medinat ha-Yehudim Street, Herzliya, 4676670

Company Facts

320 Employees
IPO DateJan 28, 2019
CountryIL
Actively Trading

Frequently Asked Questions

;